$OSCR TOP 10
Added 2025-04-14 11:19:35 +0000 UTC$OSCR continues to give us no surprises, still in the bullish descending wedge and weathering the market storm.
The wedge apex is also aligning very well with the Earnings Date on the 7th of May before the market opens.
This chart is a reminder of why we added and why this is our top pick for the year.
We are waiting for confirmation of Wave 2 to complete and enter Wave 3 where we expect this to complete at $46.
I remember in April last year when we shared the almost identical chart of $HIMS at $11 and showing it can go to $45 in a year.....it ran from $11 to $72 in 10 months instead.
I am seeing the same set up.
$PLTR was also showing a run from $11 to $45 and went as high as $120+
My questions to Joshua Kushner were important and I explained how the share price will react if they meet their targets that they have told the market and they feel confident achieving this targets.
$OSCR is expected to turn profitable this year too....exactly the same as $HIMS last year too, this will likely fuel the Wave 3 run too.
Comments
So realistically we can be buying in this area all the way down to .618 before she potentially takes off
TRob430
2025-04-14 19:51:16 +0000 UTCThank you so much for the update, CAP!!!❤️❤️❤️❤️
Sid
2025-04-14 12:14:56 +0000 UTCHmm okay yeah makes sense. Revenue boost with some margin compression. OSCR well positioned to handle vs its competitors
RealOpinions
2025-04-14 12:02:29 +0000 UTCMore people will need insurance to cover costs too
Gareth Neary
2025-04-14 11:41:41 +0000 UTCInsurance claims/costs will go up with the cost of meds no
RealOpinions
2025-04-14 11:41:01 +0000 UTCThis is not a pharma company, they sell health insurance
Gareth Neary
2025-04-14 11:40:27 +0000 UTCAre you at all worried about pharma tariff impact on OSCR?
RealOpinions
2025-04-14 11:33:03 +0000 UTC
